bioRxiv Science⌕ Search

Biology subjects

Braga, R. d. C.

Publications and source records attributed to Braga, R. d. C..

3 recordsLinked to original sources

Instance-Wise Contrastive Graph Neural Network Enables the Discovery of Novel Aedes aegypti Larvicidal Compounds

Aedes aegypti remains a major arboviral vector, making larval control a critical strategy to reduce mosquito populations. However, resistance to commercial larvicides has reduced the long-term effectiveness of current interventions, reinforcing the need for new compounds with improved potency and selectivity. Here, we present an instance-wise contrastive graph neural network (GNN) framework to accelerate the discovery of novel larvicidal compounds. The model was trained on a curated dataset of 556 organic compounds organized into LC50-derived multitask classification thresholds and integrated Transformer-inspired graph learning with whole-molecule and fragment-level contrastive regularization. This model achieved strong held-out performance, with global AUC = 0.95 {+/-} 0.01, PR-AUC = 0.93 {+/-} 0.01, and MCC = 0.77 {+/-} 0.03, outperforming conventional machine learning and graph-based baselines. Predictive uncertainty analysis and counterfactual maps further supported the interpretation of threshold-sensitive predictions and substructural contribution patterns. The model was applied to screen 1.3 million compounds, resulting in 10 candidates for experimental validation. Three compounds showed measurable larvicidal activity against A. aegypti larvae. Among them, LC-79 emerged as the most promising hit, with 2-day and 5-day LC50 values of 0.24 {micro}g/mL (0.66 {micro}M) and 0.05 {micro}g/mL (0.13 {micro}M), respectively, an IE50 of 0.06 {micro}g/mL (0.16 {micro}M), and rapid larval mortality (LT50 = 1.10 days at 1 {micro}g/mL). LC-79 also showed no measurable acute toxicity to Daphnia magna at the highest tested concentration [EC50-48h >43 {micro}g/mL (>119 {micro}M)], resulting in selectivity indices >180 and >860 relative to its 2-day and 5-day LC50 values. Overall, this study demonstrates that contrastive graph learning can move beyond retrospective larvicide modeling to experimentally validated hit discovery, identifying LC-79 as a potent and preliminarily selective acylthiourea larvicide candidate for further mechanism-of-action, resistance, and semi-field evaluation.

bioinformatics↗

Semantic-Aware Graph Embedding Approach Uncovers LC-61, a Potent Anti-Leishmania infantum Compound

Visceral leishmaniasis caused by Leishmania infantum remains a lethal disease with few therapeutic options, necessitating innovative computational methods approaches to accelerate drug discovery. Here, we present a semantic-aware graph neural network (GNN) framework that features holistic mechanisms to capture long-range molecular interactions and the chemical semantics of antileishmanial compounds. Across two classificatory antileishmanial datasets, our holistic GNNs demonstrated significant improvements in predictive performance, with area under the receiver operating characteristic curve (AUROC) increases of 2.2-29.2% on the unbalanced dataset (1 {micro}M threshold) and 3.4-22.5% on the balanced dataset (10 {micro}M threshold) compared to default GNNs. Subsequently, the framework was applied to screen a library of approximately 1.3 million compounds, pinpointing LC-61 as a potent antileishmanial agent with nanomolar activity against intracellular L. infantum (IC50 = 0.076 {micro}M) and minimal cytotoxicity to macrophages (THP-1 CC50 = 157 {micro}M). A comprehensive in vitro ADME profiling revealed that LC-61 combines high solubility at both acidic and physiological pH (>28 {micro}g/mL), balanced lipophilicity (eLogD = 4.07), and favorable passive permeability (PAMPA = 4.86 x 10-6 cm/s), while exhibiting lower microsomal stability. Overall, our semantic-aware GNN framework effectively accelerated the discovery of LC-61, a novel and biologically validated hit suitable for hit-to-lead optimization.

bioinformatics↗

Multimodal Cross-Attentive Graph-Based Framework for Predicting In Vivo Endocrine Disruptors

Endocrine hazard assessment needs models that are accurate and mechanistically transparent. We present a multimodal cross-attentive graph framework that fuses molecular graphs with adverse-outcome-pathway (AOP)-anchored assay signals to predict organism-level outcomes in the OECD Hershberger and uterotrophic assays. In Tier-1, multitask GNNs learn ER/AR molecular-initiating and key events across 46 ToxCast/Tox21 assays. In Tier-2, a cross-attentive multimodal GNN integrates Tier-1 pathway signals with molecular graphs, achieving AUROC{square}={square}0.90 (Hershberger) and 0.96 (uterotrophic). External validation on literature compounds showed 84% concordance (Hershberger 15/18; uterotrophic 22/26). Bidirectional cross-attention links molecular substructures to pathway assays and vice-versa, while counterfactual perturbations rank assays and structural motifs most responsible for each decision. The framework couples high accuracy with assay-traceable explanations, supporting targeted testing within the Integrated Approaches.

pharmacology and toxicology↗